This summary was created by AI, based on 2 opinions in the last 12 months.
According to the reviews from different experts, RadNet's stock has experienced a significant jump after the acquisition of GEH machines. One expert recommends waiting for a 5-8% pullback before buying, indicating a potentially overextended price. Overall, the consensus seems to be cautiously optimistic about the stock's performance, with attention to potential corrections in the near future.
This is the largest consolidated outpatient imaging in the US. There are about 6500 clinics that provides imaging services on an outpatient basis and RadNet has been consolidating the space. They have a few hundred of these, so there a lot more growth is possible. The private-clinic model is increasingly popular because it provides patients with lower copays. (Analyst’s price target is $16.33)
RadNet is a OTC stock, trading under the symbol RDNT-O on the (). It is usually referred to as or RDNT-O
In the last year, 2 stock analysts published opinions about RDNT-O. 2 analysts recommended to BUY the stock. 0 analysts recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for RadNet.
RadNet was recommended as a Top Pick by on . Read the latest stock experts ratings for RadNet.
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
In the last year, there was no coverage of RadNet published on Stockchase.
On , RadNet (RDNT-O) stock closed at a price of $.
It reports Friday. Ever since Radnet bought GEH machines (he owns GEH), shares have jumped $20.